Gary Calandra

8.4k citations
107 papers · 6.6k · 3 hit papers · h-index 40

Impact in

  • Hematology top 0.2%
    • Hematopoietic Stem Cell Transplantation
    • Multiple Myeloma Research and Treatments
    • Acute Myeloid Leukemia Research
  • Hepatology top 1%
    • Hepatitis Viruses Studies and Epidemiology

Papers in

Gary Calandra

104 papers receiving 6.1k citations

Gary Calandra's Hit Papers

Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma 2009 · 527 citations
5270+7+15Years since publication250500750

Peers

Gary Calandra
Comparison fields: 5 of 119
  • Hematology 2.3k
  • Hepatology 665
  • Immunology 1.7k
  • Oncology 1.7k
  • Genetics 497
Replace Carlos V. Payá with:
Carlos V. Payá United States
Steven H. Sacks United Kingdom
W. Conrad Liles United States
Christian P. Larsen United States
Jacques Bienvenu France
Rui Sun China
Tyler J. Curiel United States
Yoshiaki Ishigatsubo Japan
Stephan Ehl Germany
Jeffrey A. Gelfand United States
Gary Calandra relative to Carlos V. Payá United States Carlos V. Payá's profile →
Citations per field
00.5×7.5×
Carlos V. Payá · 1×
Citations per year

Countries citing papers authored by Gary Calandra

Since Specialization
Citations

This map shows the geographic impact of Gary Calandra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Calandra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Calandra more than expected).

Fields of papers citing papers by Gary Calandra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Calandra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Calandra. The network helps show where Gary Calandra may publish in the future.

Co-authors

The 25 scholars most cited alongside Gary Calandra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary Calandra Line = papers co-authored together Gary Calandra links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
Hit paper breakdown →
2005897
2
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
Hit paper breakdown →
2003590
3
Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma
Hit paper breakdown →
2009527
4 1992437
5 2004349
6 2008245
7 2005187
8 1988178
9 1992169
10 1982156
11 1985120
12 1988115
13 2008109
14 2007108
15 2009107
16 2009105
17 198590
18 200989
19 199186
20 198680

About Gary Calandra

Gary Calandra is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Epidemiology, Immunology and Oncology, having authored 107 papers that have together received 6.6k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (28 papers), Streptococcal Infections and Treatments (20 papers), Acute Myeloid Leukemia Research (14 papers), Hepatitis Viruses Studies and Epidemiology (10 papers), Multiple Myeloma Research and Treatments (10 papers), Neonatal and Maternal Infections (10 papers), Hepatitis B Virus Studies (9 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). The work is most often cited by research in Hematology (2.3k citations), Hepatology (665 citations), Immunology (1.7k citations), Oncology (1.7k citations) and Genetics (497 citations). Gary Calandra has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Gary Bridger, John F. DiPersio, David C. Dale, Hal E. Broxmeyer, W. Conrad Liles, Giao Hangoc, Karin Badel, Richard T. Maziarz, Patrick J. Stiff and Brent L. Wood. Their work appears in journals such as Biology of Blood and Marrow Transplantation, Clinical Infectious Diseases, Infection and Immunity, Blood and Vaccine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact